Dott. Bruno Solerte

Nome: Dott. Bruno Solerte

Specializzazione: Endocrinologia

Sede: CDI Saint Bon, CDI Largo Augusto

TITOLI ACCADEMICI

  • 1978: Laurea in Medicina e Chirurgia presso l’Università degli Studi di Pavia
  • 1981: Specializzazione in Endocrinologia presso l’Università di Pavia
  • 1987: Specializzazione in Medicina Interna

ESPERIENZE PROFESSIONALI

  • 1978-1981 Medico Interno presso la Clinica Medica I, Università  Policlinico San Matteo di Pavia
  • 1980-1981 Titolare di Guardia Medica Territoriale presso ASZ Garlasco, Pavia
  • 1981-1998 Funzionario Tecnico presso il Dipartimento di Medicina Interna, Università di Pavia
  • 1990-1995 Assistente Medico, ASP Geriatria, Pavia
  • 1991-2008 Responsabile del Servizio di Diabetologia, ASP Geriatria Pavia
  • 1998-2001 Ricercatore di Ruolo di Medicina Interna presso il Dipartimento di Medicina Interna, Università di Pavia
  • 1995-2008 Aiuto Medico e poi Dirigente di I Livello, ASP, Geriatria, Pavia
  • 2001-2018 Professore Associato di Ruolo di Medicina Interna presso il Dipartimento di Medicina Interna, Università di Pavia (posizione attuale)
  • 2008-2018 Dirigente Medico di II Livello, Direttore UOC di Geriatria presso ASP Pavia (posizione attuale) 
  • 2015-2018 Componente della Commissione Regione Lombardia per la non idoneità agonistica sportica

PRINCIPALI SETTORI ATTIVITÀ AL CDI

  • Endocrinologia 
  • Diabetologia 
  • Medicina Interna e Geriatria
  • Valutazione Multidimensionale Geriatrica
  • Auxoendocrinologia, Età scheletrica TW2

AFFILIAZIONI A SOCIETA' SCIENTIFICHE

  • Società Italiana di Diabetologia
  • Accademia di Geriatria

 

ATTIVITÀ SCIENTIFICA E PUBBLICAZIONI

 
Erectile dysfunction as a predictor of asymptomatic coronary artery disease in elderly men with type 2 diabetes.
Gazzaruso C, Coppola A, Pujia A, Falcone C, Collaviti S, Fodaro M, Gallotti P, Solerte SB, Giustina A, Pelissero G,Luzi L, Montalcini T.
J Geriatr Cardiol. 2016 Sep;13(6):552-6. doi: 10.11909/j.issn.1671-5411.2016.06.011. 

 

Twenty-four-week effects of liraglutide on body composition, adherence to appetite, and lipid profile in overweight and obese patients with type 2 diabetes mellitus.
Rondanelli M, Perna S, Astrone P, Grugnetti A, Solerte SB, Guido D.
Patient Prefer Adherence. 2016 Mar 24;10:407-13. doi: 10.2147/PPA.S97383. eCollection 2016.
 
Liraglutide and obesity in elderly: efficacy in fat loss and safety in order to prevent sarcopenia. A perspective case series study.
Perna S, Guido D, Bologna C, Solerte SB, Guerriero F, Isu A, Rondanelli M.
Aging Clin Exp Res. 2016 Dec;28(6):1251-1257. Epub 2016 Jan 9.
 
Effects of two-months balanced diet in metabolically healthy obesity: lipid correlations with gender and BMI-related differences.
Rondanelli M, Klersy C, Perna S, Faliva MA, Montorfano G, Roderi P, Colombo I, Corsetto PA, Fioravanti M, Solerte SB, Rizzo AM.
Lipids Health Dis. 2015 Oct 29;14:139. doi: 10.1186/s12944-015-0131-1.
 
Acute effect on satiety, resting energy expenditure, respiratory quotient, glucagon-like peptide-1, free fatty acids, and glycerol following consumption of a combination of bioactive food ingredients in overweight subjects.
Rondanelli M, Opizzi A, Perna S, Faliva M, Solerte SB, Fioravanti M, Klersy C, Edda C, Maddalena P, Luciano S, Paola C, Emanuela C, Claudia S, Donini LM.
J Am Coll Nutr. 2013;32(1):41-9. doi: 10.1080/07315724.2013.767667.
 
Effect of different diabetes mellitus treatments on functional decline and death in elderly adults with diabetes mellitus.
Gazzaruso C, Coppola A, Luppi C, Giustina A, Solerte SB.
J Am Geriatr Soc. 2013 Apr;61(4):666-7. doi: 10.1111/jgs.12191. No abstract available. 
 
Transcutaneous oxygen tension as a potential predictor of cardiovascular events in type 2 diabetes: comparison with ankle-brachial index.
Gazzaruso C, Coppola A, Falcone C, Luppi C, Montalcini T, Baffero E, Gallotti P, Pujia A, Solerte SB, Pelissero G, Giustina A.
Diabetes Care. 2013 Jun;36(6):1720-5. doi: 10.2337/dc12-1401. Epub 2013 Feb 12.
 
Improvement in insulin resistance and favourable changes in plasma inflammatory adipokines after weight loss associated with two months' consumption of a combination of bioactive food ingredients in overweight subjects.
Rondanelli M, Opizzi A, Perna S, Faliva M, Solerte SB, Fioravanti M, Klersy C, Cava E, Paolini M, Scavone L, Ceccarelli P, Castellaneta E, Savina C, Donini LM.
Endocrine. 2013 Oct;44(2):391-401. doi: 10.1007/s12020-012-9863-0. Epub 2012 Dec 28. Erratum in: Endocrine. 2013 Oct;44(2):402. Edda, Cava [corrected to Cava, Edda]; Maddalena, Paolini [corrected to Paolini, Maddalena]; Luciano, Scavone [corrected to Scavone, Luciano]; Paola, Ceccarelli [corrected to Ceccarelli, Paola]; Emanuela, Castellaneta [corrected to Castellaneta, Emanuela];. 
 
Improved glycemic control with weight loss and a low risk of hypoglycemia with insulin detemir: insights from the Italian cohort of the PREDICTIVE study after 6-month observation in type 2 diabetic subjects.
Perriello G, Caputo S, De Pergola G, Di Carlo A, Grassi G, Lapolla A, Pata P, Solerte SB, Zaccardi F.
Expert Opin Pharmacother. 2011 Nov;12(16):2449-55. doi: 10.1517/14656566.2011.626766. Erratum in: Expert Opin Pharmacother. 2011 Dec;12(17):2765. 
Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus.
Gazzaruso C, Coppola A, Montalcini T, Baffero E, Garzaniti A, Pelissero G, Collaviti S, Grugnetti A, Gallotti P, Pujia A, Solerte SB, Giustina A.
Endocrine. 2012 Feb;41(1):89-95. doi: 10.1007/s12020-011-9544-4. Epub 2011 Oct 11.
 
Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary artery disease in diabetes.
Gazzaruso C, Coppola A, Montalcini T, Valenti C, Garzaniti A, Pelissero G, Salvucci F, Gallotti P, Pujia A, Falcone C, Solerte SB, Giustina A.
Endocrine. 2011 Oct;40(2):273-9. doi: 10.1007/s12020-011-9523-9. Epub 2011 Aug 23.
 
Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.
Gazzaruso C, Coppola A, Montalcini T, Valenti C, Pelissero G, Solerte SB, Salvucci F, Gallotti P, Pujia A, Garzaniti A, Giustina A.
Intern Emerg Med. 2012 Jun;7(3):257-66. doi: 10.1007/s11739-011-0527-5. Epub 2011 Feb 5.
 
Life expectancy in Alzheimer's disease (AD).
Zanetti O, Solerte SB, Cantoni F.
Arch Gerontol Geriatr. 2009;49 Suppl 1:237-43. doi: 10.1016/j.archger.2009.09.035. Review.
  
Growth factors decrease in subjects with mild to moderate Alzheimer's disease (AD): potential correction with dehydroepiandrosterone-sulphate (DHEAS).
Luppi C, Fioravanti M, Bertolini B, Inguscio M, Grugnetti A, Guerriero F, Rovelli C, Cantoni F, Guagnano P, Marazzi E, Rolfo E, Ghianda D, Levante D, Guerrini C, Bonacasa R, Solerte SB.
Arch Gerontol Geriatr. 2009;49 Suppl 1:173-84. doi: 10.1016/j.archger.2009.09.027.
 
Body composition and pulmonary function in the elderly: a 7-year longitudinal study.
Rossi A, Fantin F, Di Francesco V, Guariento S, Giuliano K, Fontana G, Micciolo R, Solerte SB, Bosello O, Zamboni M.
Int J Obes (Lond). 2008 Sep;32(9):1423-30. doi: 10.1038/ijo.2008.103. Epub 2008 Jul 22.
 
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test.
Mazziotti G, Bonadonna S, Doga M, Patelli I, Gazzaruso C, Solerte SB, De Menis E, Giustina A.
Neuroendocrinology. 2008;88(4):299-304. doi: 10.1159/000144046. Epub 2008 Jul 10.
 
Administration of a dietary supplement ( N-oleyl-phosphatidylethanolamine and epigallocatechin-3-gallate formula) enhances compliance with diet in healthy overweight subjects: a randomized controlled trial.
Rondanelli M, Opizzi A, Solerte SB, Trotti R, Klersy C, Cazzola R.
Br J Nutr. 2009 Feb;101(3):457-64. doi: 10.1017/S0007114508024008. Epub 2008 Jul 1.
 
Improvement of blood glucose control and insulin sensitivity during a long-term (60 weeks) randomized study with amino acid dietary supplements in elderly subjects with type 2 diabetes mellitus.
Solerte SB, Fioravanti M, Locatelli E, Bonacasa R, Zamboni M, Basso C, Mazzoleni A, Mansi V, Geroutis N, Gazzaruso C.
Am J Cardiol. 2008 Jun 2;101(11A):82E-88E. doi: 10.1016/j.amjcard.2008.03.006.
Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia.
Solerte SB, Gazzaruso C, Bonacasa R, Rondanelli M, Zamboni M, Basso C, Locatelli E, Schifino N, Giustina A, Fioravanti M.
Am J Cardiol. 2008 Jun 2;101(11A):69E-77E. doi: 10.1016/j.amjcard.2008.03.004.
 
Erectile dysfunction as a predictor of cardiovascular events and death in diabetic patients with angiographically proven asymptomatic coronary artery disease: a potential protective role for statins and 5-phosphodiesterase inhibitors.
Gazzaruso C, Solerte SB, Pujia A, Coppola A, Vezzoli M, Salvucci F, Valenti C, Giustina A, Garzaniti A.
J Am Coll Cardiol. 2008 May 27;51(21):2040-4. doi: 10.1016/j.jacc.2007.10.069.
Relationship among nutritional status, pro/antioxidant balance and cognitive performance in a group of free-living healthy elderly.
Rondanelli M, Trotti R, Opizzi A, Solerte SB.
Minerva Med. 2007 Dec;98(6):639-45.
 
Relationship between instrumental activities of daily living and blood glucose control in elderly subjects with type 2 diabetes.
Bossoni S, Mazziotti G, Gazzaruso C, Martinelli D, Orini S, Solerte SB, Romanelli G, Giustina A.
Age Ageing. 2008 Mar;37(2):222-5. Epub 2007 Nov 21. No abstract available. 
 
Neuroendocrine features in extreme longevity.
Ferrari E, Cravello L, Falvo F, Barili L, Solerte SB, Fioravanti M, Magri F.
Exp Gerontol. 2008 Feb;43(2):88-94. Epub 2007 Jul 4.
.
Calcium metabolism and vitamin D in the extreme longevity.
Passeri G, Vescovini R, Sansoni P, Galli C, Franceschi C, Passeri M; Italian Multicentric Study on Centenarians (IMUSCE).
Exp Gerontol. 2008 Feb;43(2):79-87. Epub 2007 Jul 4. Review.
 
Safety of type 2 diabetes treatment with repaglinide compared with glibenclamide in elderly people: A randomized, open-label, two-period, cross-over trial.
Papa G, Fedele V, Rizzo MR, Fioravanti M, Leotta C, Solerte SB, Purrello F, Paolisso G.
Diabetes Care. 2006 Aug;29(8):1918-20. No abstract available. 
 
No effect of atypical antipsychotic drugs on weight gain and risk of developing type II diabetes or lipid abnormalities among nursing home elderly patients with Alzheimer's disease.
Rondanelli M, Sarra S, Antoniello N, Mansi V, Govoni S, Falvo F, Solerte SB, Ferrari E.
Minerva Med. 2006 Apr;97(2):147-51.
 
Unbalanced serum leptin and ghrelin dynamics prolong postprandial satiety and inhibit hunger in healthy elderly: another reason for the "anorexia of aging".
Di Francesco V, Zamboni M, Zoico E, Mazzali G, Dioli A, Omizzolo F, Bissoli L, Fantin F, Rizzotti P, Solerte SB, Micciolo R, Bosello O.
Am J Clin Nutr. 2006 May;83(5):1149-52.
 
Association of the metabolic syndrome and insulin resistance with silent myocardial ischemia in patients with type 2 diabetes mellitus.
Gazzaruso C, Solerte SB, De Amici E, Mancini M, Pujia A, Fratino P, Giustina A, Garzaniti A.
Am J Cardiol. 2006 Jan 15;97(2):236-9. Epub 2005 Dec 1.
 
Delayed postprandial gastric emptying and impaired gallbladder contraction together with elevated cholecystokinin and peptide YY serum levels sustain satiety and inhibit hunger in healthy elderly persons.
Di Francesco V, Zamboni M, Dioli A, Zoico E, Mazzali G, Omizzolo F, Bissoli L, Solerte SB, Benini L, Bosello O.
J Gerontol A Biol Sci Med Sci. 2005 Dec;60(12):1581-5.
 
Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients.
Gazzaruso C, Pujia A, Solerte SB, Amici ED, Emanuele E, Falcone C, Geroldi D, Giustina A, Garzaniti A.
Int J Impot Res. 2006 May-Jun;18(3):311-5.
 
Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
Gazzaruso C, Bruno R, Pujia A, De Amici E, Fratino P, Solerte SB, Garzaniti A.
Int J Cardiol. 2006 Apr 14;108(3):354-8. Epub 2005 Jun 14.
 
Defect of a subpopulation of natural killer immune cells in Graves' disease and Hashimoto's thyroiditis: normalizing effect of dehydroepiandrosterone sulfate.
Solerte SB, Precerutti S, Gazzaruso C, Locatelli E, Zamboni M, Schifino N, Bonacasa R, Rondanelli M, Taccani D, Ferrari E, Fioravanti M.
Eur J Endocrinol. 2005 May;152(5):703-12.
 
Current guidelines for adult GH replacement.
Doga M, Bonadonna S, Gola M, Solerte SB, Amato G, Carella C, Giustina A.
Rev Endocr Metab Disord. 2005 Jan;6(1):63-70. Review. No abstract available. 
 
Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate.
Solerte SB, Ferrari E, Cuzzoni G, Locatelli E, Giustina A, Zamboni M, Schifino N, Rondanelli M, Gazzaruso C, Fioravanti M.
Dement Geriatr Cogn Disord. 2005;19(1):1-10. Epub 2004 Sep 21.
 
Endocrine pancreatic dysfunction in HIV-infected children: association with growth alterations.
Rondanelli M, Caselli D, Trotti R, Solerte SB, Maghnie M, Maccabruni A, Minoli L, Ferrari E.
J Infect Dis. 2004 Sep 1;190(5):908-12. Epub 2004 Jul 23.
 
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients.
Gazzaruso C, Giordanetti S, De Amici E, Bertone G, Falcone C, Geroldi D, Fratino P, Solerte SB, Garzaniti A.
Circulation. 2004 Jul 6;110(1):22-6. Epub 2004 Jun 21.
 
Cognitive and affective disorders in the elderly: a neuroendocrine study.
Ferrari E, Mirani M, Barili L, Falvo F, Solerte SB, Cravello L, Pini L, Magri F.
Arch Gerontol Geriatr Suppl. 2004;(9):171-82.
PMID:
 
Metabolic effects of orally administered amino acid mixture in elderly subjects with poorly controlled type 2 diabetes mellitus.
Solerte SB, Gazzaruso C, Schifino N, Locatelli E, Destro T, Ceresini G, Ferrari E, Fioravanti M.
Am J Cardiol. 2004 Apr 22;93(8A):23A-29A.